Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma (Q69875757)
scientific article published on 01 December 1985
Language:
(P31) (Q13442814)
(P50) (Q2347448)
(P304) 4273-4280
(P407) (Q1860)
(P433) 6
(P478) 135
(P577) Sunday, December 1, 1985
(P921) (Q1427096)
(Q356033)
(P1433) (Q3521441)
(P1476) "Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma" (language: en)
(P2093) Lafreniere R
other details
description scientific article published on 01 December 1985

External Links